Measurement scales of mental health related to climate change : a scoping review protocol using artificial intelligence

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..

INTRODUCTION: Human actions have influenced climate changes around the globe, causing extreme weather phenomena and impacting communities worldwide. Climate change has caused, directly or indirectly, health effects such as injury and physical injuries, which impact morbidity and mortality. Similarly, there is evidence that exposure to climatic catastrophes has serious repercussions on psychological well-being, and rising temperatures and drought have detrimental effects on mental health.Despite the recent effort of researchers to develop specific instruments to assess the effects of climate change on mental health, the evidence on measures of its impact is still scarce, and the constructs are heterogeneous. The aim of this scoping review is to describe the instruments developed and validated to assess the impact of mental health related to climate change.

METHODS AND ANALYSIS: This review is registered at Open Science Framework (https://osf.io/zdmbk). This scoping review will follow the reporting elements chosen for systematic review and meta-analysis (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). We proposed a PO question, as it places no restrictions on the participants (P), and the outcome (O) are measurement instruments on mental health related to climate change. A search will be conducted in different databases (PubMed, Scopus, Web of Science, PsycINFO). We will use an open-source artificial intelligence screening tool (ASReview LAB) for the title and abstract review. The full-text review will be performed by three researchers. If there is a disagreement between two independent reviewers, a third reviewer will take the final decision. We will use the COnsensus-based Standards for the selection of health Measurement INstruments tool to assess the risk of bias for each included study. The review will be conducted starting in September 2023.

ETHICS AND DISSEMINATION: The planned scoping review does not require ethical approval since it will not involve an ethical risk to the participants. The results obtained from this study will be presented at conferences, congresses and scientific publications.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

BMJ open - 13(2023), 10 vom: 11. Okt., Seite e071073

Sprache:

Englisch

Beteiligte Personen:

Dominguez-Rodriguez, Alejandro [VerfasserIn]
Villarreal-Zegarra, David [VerfasserIn]
Malaquias-Obregon, Sofía [VerfasserIn]
Herdoiza-Arroyo, Paulina Erika [VerfasserIn]
González-Cantero, Joel Omar [VerfasserIn]
Chávez-Valdez, Sarah Margarita [VerfasserIn]
Cruz-Martínez, Roberto Rafael [VerfasserIn]

Links:

Volltext

Themen:

Anxiety disorders
Clinical Trial Protocol
Depression & mood disorders
Journal Article
MENTAL HEALTH
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 15.10.2023

Date Revised 20.10.2023

published: Electronic

Citation Status MEDLINE

doi:

10.1136/bmjopen-2022-071073

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM363141928